首页|血液透析滤过和血液灌流对MHD患者钙、磷、甲状旁腺激素及营养状态的影响分析

血液透析滤过和血液灌流对MHD患者钙、磷、甲状旁腺激素及营养状态的影响分析

扫码查看
目的 探究不同血液透析滤过(HDF)、血液灌流(HP)治疗频率对维持性血液透析(MHD)患者血钙、血磷、甲状旁腺激素及营养状态的影响.方法 选取 135 例MHD患者作为研究对象,采用随机数字表法分为A组、B组和C组,每组 45 例.A组为每 4 周行低通量血液透析(LFHD)12 次治疗;B组为每 4 周行LFHD 10 次、HDF 1 次、LFHD+HP 1 次治疗;C组为每 4 周行LFHD 8 次、HDF 2 次、LFHD+HP 2 次治疗.比较三组患者的血钙、血磷、甲状旁腺激素及营养状态指标[血清白蛋白(ALB)、血红蛋白(Hb)].结果 治疗前,A组甲状旁腺激素、血磷、血钙水平分别为(357.79±235.00)pg/ml、(2.01±0.72)mmol/L、(1.82±0.28)mmol/L,B组分别为(343.44±225.90)pg/ml、(2.11±0.77)mmol/L、(1.87±0.27)mmol/L,C组分别为(395.10±267.41)pg/ml、(2.32±0.80)mmol/L、(1.95±0.26)mmol/L;治疗后,A组甲状旁腺激素、血磷、血钙水平分别为(380.51±307.68)pg/ml、(2.22±0.86)mmol/L、(1.86±0.26)mmol/L,B组分别为(264.58±131.71)pg/ml、(1.85±0.58)mmol/L、(1.99±0.20)mmol/L,C组分别为(304.38±191.63)pg/ml、(1.93±0.50)mmol/L、(2.02±0.23)mmol/L.三组治疗前甲状旁腺激素、血磷及血钙水平对比,差异均无统计学意义(P>0.05);三组治疗后甲状旁腺激素、血磷及血钙水平有统计学差异(P<0.05).A组治疗前后血钙、血磷、甲状旁腺激素水平组内对比无统计学意义(P>0.05).B组、C组治疗后血磷、甲状旁腺激素水平比治疗前低(P<0.05),血钙水平比治疗前高(P<0.05),但B组与C组治疗后甲状旁腺激素、血磷及血钙水平对比,差异无统计学意义(P>0.05).治疗前,A组ALB、Hb水平分别为(36.44±5.25)、(75.89±18.52)g/L,B组分别为(35.10±5.76)、(80.02±18.61)g/L,C组分别为(37.12±5.77)、(79.90±18.17)g/L;治疗后,A组ALB、Hb水平分别为(37.45±4.89)、(84.93±23.54)g/L,B组分别为(39.87±4.70)、(100.16±19.48)g/L,C组分别为(40.03±4.62)、(100.02±21.08)g/L.治疗前,三组ALB、Hb水平对比无显著差异(P>0.05);治疗后,三组Hb水平较治疗前均有升高,有统计学意义(P<0.05);A组治疗后ALB水平较治疗前有升高,但差异无统计学意义(P>0.05);B组、C组治疗后ALB水平较治疗前升高,有统计学差异(P<0.05),但B组与C组治疗后ALB水平对比,差异无统计学意义(P>0.05).结论 对MHD患者单纯采取LFHD治疗未能有效改善患者钙磷代谢紊乱及继发性甲状旁腺功能亢进,而结合HDF和HP治疗能更好清除血磷、甲状旁腺素及升高血钙.增加HDF和HP的频率,不会增加患者营养不良的发生,但对改善患者钙磷代谢紊乱及继发性甲状旁腺功能亢进无进一步疗效.
Analysis of the effects of hemodiafiltration and hemoperfusion on calcium,phosphorus,parathyroid hormone and nutritional status in MHD patients
Objective To explore the effects of hemodiafiltration(HDF)and hemoperfusion(HP)on calcium,phosphorus,parathyroid hormone and nutritional status in maintenance hemodialysis(MHD)patients.Methods 135 patients were selected as the research subjects,and the patients were divided into group A,group B and group C according to random numerical table,with 45 cases in each group.Group A was treated with 12 sessions of low-flux hemodialysis(LFHD)every 4 weeks;Group B was treated with 10 sessions of LFHD,1 session of HDF,and 1 session of LFHD+HP every 4 weeks;Group C was treated with 8 sessions of LFHD,2 sessions of HDF,and 2 sessions of LFHD+HP every 4 weeks.The blood calcium,blood phosphorus,parathyroid hormone and nutritional status indicators[serum albumin(ALB)and hemoglobin(Hb)]of the three groups were compared.Results Before treatment,the levels of parathyroid hormone,blood phosphorus and blood calcium in group A were(357.79±235.00)pg/ml,(2.01±0.72)mmol/L and(1.82±0.28)mmol/L,those in group B were(343.44±225.90)pg/ml,(2.11±0.77)mmol/L and(1.87±0.27)mmol/L,and those in group C were(395.10±267.41)pg/ml,(2.32±0.80)mmol/L and(1.95±0.26)mmol/L.After treatment,the levels of parathyroid hormone,blood phosphorus and blood calcium in group A were(380.51±307.68)pg/ml,(2.22±0.86)mmol/L and(1.86±0.26)mmol/L,those in group B were(264.58±131.71)pg/ml,(1.85±0.58)mmol/L and(1.99±0.20)mmol/L,and those in group C were(304.38±191.63)pg/ml,(1.93±0.50)mmol/L and(2.02±0.23)mmol/L.Before treatment,there were no statisticall difference in parathyroid hormone,blood phosphorus and blood calcium levels among the three groups(P>0.05).After treatment,the levels of parathyroid hormone,blood phosphorus and blood calcium were compared among the three groups,and there was statistical difference(P<0.05).There was no statistical significance in blood calcium,blood phosphorus and parathyroid hormone levels in group A before and after treatment(P>0.05).The levels of blood phosphorus and parathyroid hormone after treatment in group B and group C were lower than those before treatment(P<0.05),and the level of blood calcium was higher than that before treatment(P<0.05),but there was no statistically significant difference in the comparison of the levels of parathyroid hormone,blood phosphorus,and blood calcium between group B and group C after treatment(P>0.05).Before treatment,ALB and Hb levels were(36.44±5.25)and(75.89±18.52)g/L in group A,(35.10±5.76)and(80.02±18.61)g/L in group B,and(37.12±5.77)and(79.90±18.17)g/L in group C,respectively.After treatment,ALB and Hb levels were(37.45±4.89)and(84.93±23.54)g/L in group A,(39.87±4.70)and(100.16±19.48)g/L in group B,and(40.03±4.62)and(100.02±21.08)g/L in group C,respectively.Before treatment,there was no significant difference in ALB and Hb levels among the three groups(P>0.05).After treatment,Hb levels of all three groups were elevated compared with those before treatment,and there was statistical significance(P<0.05).ALB levels were elevated in group A after treatment compared with that before treatment,but there was no statistical difference(P>0.05).ALB levels in group B and group C were elevated after treatment compared with that before treatment,and there was statistical significance(P<0.05),but there was no statistical difference in ALB level between group B and group C after treatment(P>0.05).Conclusion For MHD patients,LFHD treatment alone failed to effectively improve calcium and phosphorus metabolism disorders and secondary hyperparathyroidism in patients.Combined treatment with HDF and HP can better clear blood phosphorus,parathyroid hormone and increase blood calcium,increase the frequency of HDF and HP,and will not increase the incidence of malnutrition in patients,but this method has no further effect on improving calcium and phosphorus metabolism disorders and secondary hyperparathyroidism in patients.

HemodiafiltrationHemoperfusionMaintenance hemodialysisCalciumPhosphorusParathyroid hormoneNutritional status

黄禄海

展开 >

537300 平南县人民医院肾内科

血液透析滤过 血液灌流 维持性血液透析 甲状旁腺激素 营养状态

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(12)